The potential risks of C-C chemokine receptor 5-edited babies in bone development

被引：0

作者：

Yong Xie ^{[1
]}

Shaohua Zhan ^{[2
]}

Wei Ge ^{[2
]}

Peifu Tang ^{[1
]}

机构：

[1] Department of Orthopedics,Chinese PLA General Hospital

[2] State Key Laboratory of Medical Molecular Biology and Department of Immunology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences

来源：

Bone Research | 2019年 / 01期

基金：

中国国家自然科学基金;

关键词：

CCR; The potential risks of C-C chemokine receptor 5-edited babies in bone development;

D O I：

暂无

中图分类号：

R714.8 [];

学科分类号：

摘要：

INTRODUCTION Hutter et al.1first reported that a bone marrow transplant using stem cells derived from a donor with homozygous CCR5 delta32gene mutation remained HIV-positive but virus-free (below the limits of detection) after halting antiretroviral therapy.Since this observation in 2009,mutation of the CCR5 gene has become an important target in the prevention and treatment of HIV infection.

引用

页码：118 / 121

页数：4

共 50 条

[1] The potential risks of C-C chemokine receptor 5-edited babies in bone development
Yong Xie
Shaohua Zhan
Wei Ge
Peifu Tang
Bone Research, 7
[2] The potential risks of C-C chemokine receptor 5-edited babies in bone development
Xie, Yong
Zhan, Shaohua
Ge, Wei
Tang, Peifu
BONE RESEARCH, 2019, 7 (1)
[3] The potential risks of C-C chemokine receptor 5-edited babies in bone development
Yong Xie
Shaohua Zhan
Wei Ge
Peifu Tang
Bone Research, 2019, 7 (01) : 118 - 121
[4] C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection
Dorak, MT
Folayan, GO
Niwas, S
van Leeuwen, DJ
Yee, LJ
Tang, JM
Kaslow, RA
IMMUNOLOGIC RESEARCH, 2002, 26 (1-3) : 167 - 175
[5] C-C chemokine receptor 2 and C-C chemokine receptor 5 genotypes in patients treated for chronic hepatitis C virus infection
M. Tevfik Dorak
Gbolahan O. Folayan
Santosh Niwas
Dirk J. van Leeuwen
Leland J. Yee
Jianning Tang
Richard A. Kaslow
Immunologic Research, 2002, 26 : 167 - 175
[6] C-C motif chemokine ligand 5 and C-C chemokine receptor type 5: possible diagnostic application in breast cancer patients
Dabrowska, Emilia
Przylipiak, Andrzej
Zajkowska, Monika
Piskor, Barbara Maria
Borowik-Zareba, Aleksandra
Lawicki, Slawomir
ACTA BIOCHIMICA POLONICA, 2020, 67 (04) : 539 - 545
[7] Expression of the C-C chemokine receptor 5 in human kidney diseases
Segerer, S
Mack, M
Regele, H
Kerjaschki, D
Schlöndorff, D
KIDNEY INTERNATIONAL, 1999, 56 (01) : 52 - 64
[8] C-C Chemokine Receptor 7 in Cancer
Bill, Colin A.
Allen, Christopher M.
Vines, Charlotte M.
CELLS, 2022, 11 (04)
[9] Chemokine (C-C motif) Receptor 5 Is an Important Pathological Regulator in the Development and Maintenance of Neuropathic Pain
Matsushita, Katsuyuki
Tozaki-Saitoh, Hidetoshi
Kojima, Chinami
Masuda, Takahiro
Tsuda, Makoto
Inoue, Kazuhide
Hoka, Sumio
ANESTHESIOLOGY, 2014, 120 (06) : 1491 - 1503
[10] C-C chemokine receptor type 5 is an important pathological regulator in the development and maintenance of neuropathic pain
Matsushita, Katsuyuki
Kojima, Chinami
Tozaki-Saitoh, Hidetoshi
Tsuda, Makoto
Hoka, Sumio
Inoue, Kazuhide
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 186P - 186P

← 1 2 3 4 5 →